This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Synchrony (SYF) Frees Up Capital With the Sale of Pets Best
by Zacks Equity Research
Synchrony's (SYF) divestiture of Pets Best is expected to free up capital and expand Care Credit's reach to pet owners.
Synchrony (SYF) Up 7.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Synchrony (SYF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synchrony (SYF) Joins Forces With Big Brand Tire & Service
by Zacks Equity Research
The new partnership will strategically expand Synchrony's (SYF) market reach in automotive financing.
Rithm Capital (RITM) Shares Up 10% Since Q3 Earnings Release
by Zacks Equity Research
Rithm Capital's (RITM) Q3 results indicate higher interest income and strong contribution from the Servicing segment, partly offset by an escalating expense base.
SYF vs. BX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SYF vs. BX: Which Stock Is the Better Value Option?
Synchrony (SYF) Q3 Earnings Beat on Growing Purchase Volume
by Zacks Equity Research
Synchrony (SYF) expects loan receivables to grow 11% for 2023, up from the previous guidance of 8-10%.
Synchrony (SYF) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Synchrony (SYF) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synchrony (SYF) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Synchrony (SYF) delivered earnings and revenue surprises of 2.78% and 1.58%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Rising Expenses Affect Synchrony's (SYF) Q3 Earnings?
by Zacks Equity Research
Synchrony's (SYF) third-quarter results are likely to reflect lower net interest margins and higher total average active accounts.
Moody's (MCO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Moody's (MCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Synchrony (SYF) Q3 Earnings Expected to Decline
by Zacks Equity Research
Synchrony (SYF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Synchrony Financial (SYF) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Synchrony (SYF) & Veterinary Growth to Offer Pet Care Financing
by Zacks Equity Research
Synchrony (SYF) collaborates with Veterinary Growth to provide pet care financing solutions to its members.
SYF or BX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYF vs. BX: Which Stock Is the Better Value Option?
Why Investors Are Retaining Blue Owl Capital (OBDC) Stock Now
by Zacks Equity Research
The high-interest rate environment is projected to drive Blue Owl Capital's (OBDC) investment income this year.
SYF vs. BX: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYF vs. BX: Which Stock Is the Better Value Option?
Are Investors Undervaluing Synchrony Financial (SYF) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Investors Are Retaining Synchrony (SYF) Stock Now
by Zacks Equity Research
Synchrony's (SYF) Health & Wellness platform is expected to continue its growth track, thanks to a solid CareCredit brand.
Synchrony's (SYF) CareCredit Offers Pet Care Financing Option
by Zacks Equity Research
Synchrony (SYF) collaborates with the University of Missouri, Oregon State University and Virginia Tech to provide pet care financing solutions.
Synchrony (SYF) Offers Financing Options in Dental Care
by Zacks Equity Research
Synchrony Financial (SYF) ties up with Specialty1 Partners to extend financing alternatives to customers opting for dental care, as well as shield them from unexpected medical expenses.
Synchrony Financial (SYF) Up 10% in 3 Months: Growth Ahead?
by Zacks Equity Research
Synchrony Financial's (SYF) focus on creating new partnerships and expanding old ones is expected to position the company for long-term growth.
Why Is Synchrony (SYF) Down 9% Since Last Earnings Report?
by Zacks Equity Research
Synchrony (SYF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synchrony (SYF) and Floor & Decor Partner for Financing Options
by Zacks Equity Research
Synchrony's (SYF) multi-year partnership with Floor & Decor is expected to provide customers with suitable financing and payment options.
Rithm Capital (RITM) Shares Dip 0.5% Despite Q2 Earnings Beat
by Zacks Equity Research
Rithm Capital's (RITM) Q2 results indicate strong contributions from the Residential Securities, Properties and Loans unit, partly offset by escalating general and administrative costs.
CNO Financial's (CNO) Q2 Earnings Miss on Higher Expenses
by Zacks Equity Research
CNO Financial (CNO) expects 2023 EPS in the range of $2.65-$2.85, indicating a decline from the 2022 figure of $3.06.